Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Letter From The Editor Previous | All Articles This Week | Next
This article originally posted 01 December, 2011 and appeared in  Medication, Best of GLP-1

Editor's Note: The Best of the Best of Our GLP-1 Series

When it comes to knowledge sometimes you just can't get enough when you are interested in a topic. Over the past six months we have spent a lot of time giving you the most-up-to-date and relevant information on GLP-1 therapy that we could find. We have provided interviews with thought leaders, surveys of your colleagues, Homerun Slides, and patient case studies. Your response to this information has been overwhelming, so to make it easier to find the most popular, cutting-edge articles on GLP-1 therapy, we have put together this Special Edition, Best of GLP-1, for you.
Advertisement

Related Articles

FDA Approves Two Generics of Clopidogrel (Plavix) FDA Approves Labeling Changes for All Statins Two New Weight Loss Drugs Approved by FDA Advisory Committee
Advertisement

 

Bookmark and Share | Print | Category | Home

This article originally posted 01 December, 2011 and appeared in  Medication, Best of GLP-1

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control

Cardiovascular CE & CME Clinical Slides Drugs Affecting BG Safety Tools Test Your Knowledge Medications Polls Obesity Case Studies Jobs Interviews GLP-1 Agonist Sheri R. Colberg, PhD

Announcement:
 

Free Weekly Newsletter
Sign up here.

Free CE Available
CE Programs on diabetes

Search Articles On Diabetes In Control